Preventing Infant RSV: Examining Opportunities for Monoclonal Antibody Products in the Vaccines for Children Program
This content is restricted to members only. Please login below.
Respiratory Syncytial Virus (RSV) is a leading cause of hospitalizations for infants and young children. Infections from RSV lead to 100-300 deaths, 58,000-80,000…
The COVID-19 pandemic has heightened the importance of the 2020-21 flu vaccination campaign. Recent research suggests that having flu and COVID-19 doubles the…